Search Within

Ronald A Ghossein

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (9)
  3. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (54)
  2. Epidemiology and Biostatistics (54)
  3. GSK Faculty (42)
  4. Surgery (41)
  5. Biostatistics Service (36)
  6. Center for Pancreatic Cancer Research (36)

More Groups

People
  1. James Fagin (22)
  2. Robert Tuttle (18)
  3. Ian Ganly (16)
  4. Nicholas Socci (14)
  5. Nikolaus Schultz (14)
  6. Chris Sander (13)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (15)
  6. 2019 (5)

More Years

Publications
  1. Nature Communications (10)
  2. Clinical Cancer Research (5)
  3. European Journal of Nuclear Medicine and Molecular Imaging (4)
  4. Journal of Clinical Oncology (4)
  5. Journal of Clinical Endocrinology and Metabolism (3)
  6. Thyroid (3)

More Publications

Publishers
  1. Nature Publishing Group (14)
  2. Springer (8)
  3. American Association for Cancer Research (7)
  4. American Society of Clinical Oncology (4)
  5. Oxford University Press (4)
  6. Mary Ann Liebert, Inc (3)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [(18)F]TFB PET/CT misses intense [(124)I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
    Journal Article

    Backhaus, P.; Pentlow, K. S.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy
    Journal Article

    Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma
    Journal Article

    Ganly, I.; Liu, E. M.; Kuo, F.; Makarov, V.; Dong, Y.; Park, J.; Gong, Y.; Gorelick, A. N.; Knauf, J. A.; Benedetti, E.; more...
    Science Advances (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Characterization of subtypes of BRAF-mutant papillary thyroid cancer defined by their thyroid differentiation score
    Journal Article

    Boucai, L.; Seshan, V.; Williams, M.; Knauf, J. A.; Saqcena, M.; Ghossein, R. A.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2022)

    Fulltext@MSK | Save
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save